Re-imagine clinical research with digital objective assessments

Transform real-world data and evidence collection, from pre-clinical to drug commercialization, by understanding patients symptoms through their smartphones

Top 10 Global Pharma Companies are transforming their R&D with Beats Medical

Deploy Beats Medical’s digital platform in a white-labeled or co-branded solution that integrates into your clinical pipeline, delivering objective assessments to enhance your R&D activities from pre-clinical to commercialization, or even to provide tailored digital therapies that drive long term behavioural change.

Our cross-disease, multi-symptom platform technology, Colbolt©, requires no additional hardware and provides the broadest reach on the market across iOS and Android devices to capture precision data on complex conditions.

Read more about what Colbolt© can do here.

Re-imagine
clinical research

Defining your digital strategy for clinical research shouldn’t be hard. Make it simple by translating your needs to generate evidence from pre-clinical to commercialization through a strong digital strategy, supported by a team of clinical and digital experts.

Re-imagine
clinical research

Utilize digital assessments supported by AI to rapidly learn about specific diseases, without managing logistics or distributing hardware to patients. Unlock the right endpoints for your clinical trial from the start.

Re-imagine
clinical research

Move through the clinical trial phases to drug approval with the support of digital assessments that will accelerate your progress toward better clinical outcomes. Learn faster and make the right decisions about your assets in real time.

Smartphone-based assessments
adaptable to
every trial

Cross-disease and
Multi-symptom

Provide objective measures of mobility, fine motor, and speech alongside QoL/ePROMs

Bring your own device (BYOD)

Limitless recruitment of patients across devices and geographies, with no additional wearable

x5 increase in
data precision

Use standardized digital assessments with a 5-fold increase compared to traditional methods

Embedded digital biomarkers approach

Explore measures that become the foundations for digital biomarkers in complex conditions

Our
Partners

We are proud to work with industry leading partners to better understand, engage and treat patients with CNS and rare conditions.

Our aim is to generate better outcomes for all by partnering for scale. Our partnerships deliver win – wins for our clients with a low barrier to entry and a high percentage of success.

Trusted by

97 million

steps taken by our users around the world

30+ countries

where our solution is commercialised

11 years

leading the field of digital clinical research

    Contact Us